Stocktoria

Nuvation Bio Inc. NUVB

NYSE · stock · Pharmaceutical Preparations · website · IPO 2020-07-01 · LEI

Nuvation Bio Inc. statistics & valuation

Market cap$2.0B
P / S31.4×
P / B6.5×
Net margin-325.3%
Return on equity-66.9%
Net cash$116.9M
Enterprise value USD$1.9B
Earnings yield EBIT/EV-11.5%
Return on capital-41.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-7213.80% -325.30% 202020212022202320242025
Gross margin (%)
10.10% 202020212022202320242025
Operating margin (%)
-7527.30% -338.70% 202020212022202320242025
Return on equity (%)
-19.40% -11.60% -15.90% -12.50% -122.50% -66.90% 202020212022202320242025
Shares outstanding
149.0M 217.9M 218.6M 219.0M 337.8M 346.5M 202020212022202320242025
Net debt ($)
-$116.9M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-18.80% -11.20% -15.50% -12.20% -105.10% -34.40% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
0.15× 202020212022202320242025
EPS ($)
-$0.44 -$0.48 -$0.35 -$2.11 -$0.60 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin—10.1%————
Operating margin-338.7%-7527.3%————
Net margin-325.3%-7213.8%————
Return on assets-34.4%-105.1%-12.2%-15.5%-11.2%-18.8%
Return on equity-66.9%-122.5%-12.5%-15.9%-11.6%-19.4%
Debt / equity0.15×—————
Current ratio6.959.0444.1150.7045.6233.69

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.